Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.05M Hold
5,400
– – ﹤0.01% 1666
2026
Q1
$1.21M Sell
5,400
-6,700
-55% -$1.67M ﹤0.01% 1609
2025
Q4
$2.91M Buy
12,100
+4,500
+59% +$1.15M 0.01% 1225
2025
Q3
$2.08M Buy
7,600
+2,200
+41% +$601K ﹤0.01% 1480
2025
Q2
$1.39M Buy
+5,400
New +$1.29M ﹤0.01% 1631

Other funds holding RMD

PEAK6's RMD Position: Q2 2026 in Review

PEAK6 opened a new position in ResMed (RMD) in Q2 2026: 689 shares worth $134K. The stake represents ﹤0.01% of the portfolio and ranks #2356 among its holdings. This is a return to the name: PEAK6 previously reported a position in RMD as recently as Q1 2025.

PEAK6 first reported a position in RMD in Q4 2024 and has held it in 3 quarters since. The position peaked at $716K in Q4 2024. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • PEAK6 held 689 shares of ResMed worth $134K as of Q2 2026.
  • ResMed was a new PEAK6 position in Q2 2026.
  • ResMed made up ﹤0.01% of PEAK6's portfolio in Q2 2026, its #2356 holding.
  • PEAK6 first reported a position in ResMed in Q4 2024 and has held it in 3 quarters since.
  • PEAK6's ResMed position peaked at $716K in Q4 2024.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.